by GMFH Editing Team
Fecal microbiota transplantation is being studied in the context of metabolic health, beyond its use for recurrent Clostridioides difficile infection. A new proof-of-principle study reveals that supplementing low-fermentable fiber following fecal microbiota transplantation may improve insulin sensitivity in individuals with severe obesity.
by GMFH Editing Team
Restoring maternal microbes immediately after birth, in a practice dubbed ‘vaginal seeding’, has been suggested as a means of improving microbiome development in cesarean-born neonates. Two new studies come to contradictory findings, however, highlighting the need for more clinical trials before the practice is generalized.
by GMFH Editing Team
We have known for a while that obesity has a microbial component. Now, a team of scientists led by Patrice D. Cani reports a novel bacterium isolated from the human gut that counteracts diet-induced obesity, inflammation and glucose dysregulation in mice.
Dr. Barbara is Professor of Internal Medicine and Gastroenterology at the University of Bologna. His research focuses on neurogastroenterology, brain-gut interactions, and the intestinal microenvironment (microbiota-host interactions). He is member of the Steering Committee of ESNM and member of the Board of Directors of the Rome Foundation. He holds the Master Award in Gastroenterology for Basic and Clinical Research in Digestive Science from the American Gastroenterological Association.
Research Director at the French National Research Institute for Agriculture, Food and Environment, INRAE, Dr. Joël Doré is currently Scientific Director of the Pre-Industrial Demonstrator MetaGenoPolis, a platform of excellence dedicated to quantitative and functional metagenomics, funded by the French government Futures Investments. He is co-lead of a research team of the MICALIS institute “Food and Gut Microbiology for Human Health”.by GMFH Editing Team
According to the Celiac Disease Foundation, celiac disease affects 1 in 100 people worldwide. To mark International Coeliac Day, GMFH interviews Dr Elena Verdú from McMaster University (Canada), who explains some key facts about the condition.
Daniel Pohl is Head of the Neurogastroenterology and Motility Unit at the University Hospital Zurich, Switzerland. Besides managing a very busy clinic his research interests include upper gut motility and dysmotility, nutrient intolerance and disorders of brain-gut interaction. Daniel is the co-founder of the Swiss Society of Neurogastroenterology and Motility (SwissNGM) and Member of the executive committee of the European Society of Neurogastroenterology and Motility (ESNM).Analysing the molecular and biochemical mechanisms disturbing the complex network of communication is key to our understanding of the pathophysiology of the functional GI disorders. Together with ESNM we have prepared an exciting webinar series under the topic: Microbiota and Gut-Brain Connection: A new Frontier in Neurogastroenterology. This free resource is a great opportunity to hear leading worldwide experts presenting the most recent findings on this topic.
by GMFH Editing Team
In 2020, we saw important scientific advances in our understanding of how the gut microbiome contributes to human health beyond the gastrointestinal milieu. Discover the year’s breakthroughs in this “2020 Year at a glance” report.
This year’s research has brought to light many interesting advances in the field of gut health and has unveiled some of the microbiota’s secrets. We have discussed the impact of diet, immunity, fermented foods, the characteristics of gut health, and of course we also covered COVID-19. So, can you guess what GMFH’s 10 most popular articles of 2020 were?
